Sen. Committee Clears Drug Disclosure, Biosimilar Bills
By Dani Kass · June 17, 2026, 8:40 PM EDT
The U.S. Senate Committee on Health, Education, Labor and Pensions on Wednesday cleared two bills for full Senate review, tackling the gap between health and patent oversight agencies, and the need...
To view the full article, register now.